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This review provides examples of the fact that different procedures for the measurement of atherosclerosis in mice may lead to
interpretation of the extent of atherosclerosis having markedly different biological and clinical significance for humans: 1) aortic
cholesterol measurement is highly sensitive for the detection of early and advanced atherosclerosis lesions, but misses the
identification of the location and complexity of these lesions that are so critical for humans; 2) the histological analysis of the
aortic root lesions in simvastatin-treated and control mice reveals similar lesion morphology in spite of the remarkable
simvastatin-induced reduction of the aortic cholesteryl ester content; 3) in histological analyses, chemical fixation and inclusion
may extract the tissue fat and also shrink and distort tissue structures. Thus, the method may be less sensitive for the detection
of slight differences among the experimental groups, unless a more suitable procedure employing physical fixation with
histological sample freezing using optimal cutting temperature and liquid nitrogen is employed. Thus, when measuring
experimental atherosclerosis in mice, investigators should be aware of several previously unreported pitfalls regarding the
extent, location and complexity of the arterial lesion that may not be suitable for extrapolation to human pathology.
Key words: Atherosclerosis; Animal models; Disease models; Aorta; Pathology
Research supported by PRONEX (CNPq #66.1092/1997-2), FAPESP, and Medical Investigation Laboratory of Hospital das
Clínicas (LIM), Faculty of Medical Sciences, University of São Paulo.
Received July 25, 2008. Accepted March 11, 2009
Introduction
Rabbits, rats, mice, pigeons, pigs, and monkeys are
often used in atherosclerosis research, but in some of
these species the plasma lipoprotein profile and the pat-
tern of atherosclerosis lesion differ from those of humans.
Rats, for example, are not suitable models for atheroscle-
rosis research because they do not develop vascular
lesion spontaneously, unless fed an extremely athero-
genic diet (1). For these reasons, most of the atherosclero-
sis studies have been previously restricted to rabbits, pigs
and primates. However, handling difficulties, large ani-
mals’ breeding expenses and the risk of non-human pri-
mate extinction have increased the need for the develop-
ment of murine models of atherosclerosis (2,3). Other
parameters that are considered in the choice of a model
are breeding time and rate and intensity of lesion develop-
ment, as well as the facilities needed to perform experi-
ments. These needs have led to the development of ge-
netically modified mice as models for experimental athero-
sclerosis (4) that include random insertion of new genes,
insertion of specific mutations in the loci of the wild-type
alleles, and disruption of a specific allele (3). Several
genetically modified mice present an altered lipoprotein
profile, often similar to that of human dyslipidemias, suit-
able for investigations of the arterial lesions (5), such as
apolipoprotein E (apoE) or low-density lipoprotein receptor
(LDLR) knockouts (KO). Both models are hyperlipidemic;
however, the apoE KO animals, even when fed a chow
diet, display more severe or complex lesions than LDLR
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KO mice fed a western diet (6-10).
Atherosclerosis can be measured by several methods
such as size of the lesions, cell types and biochemical
changes that take place at distinct sites of the vascular bed
due to exposure to diverse hemodynamic forces. Addition-
ally, precision, cost and technical convenience are impor-
tant factors that lead to the choice of the procedure used
for the histological and chemical methods of atherosclero-
sis quantification. Since the technical details of each meth-
od have been properly described elsewhere (references in
the text below), the purpose of the present review was to
discuss the adequacy of each histological and chemical
procedure regarding the objectives of the experimental
design used to produce atherosclerosis.
Analysis of aortic intima (en face)
Briefly, a longitudinal incision is performed in the inner
curvature of the aortic arch through the anterior surface as
far as the distal aorta. An identical surgical procedure is
carried out in the outer curvature of the aortic arch as far as
the subclavian branch. The aorta is then pinned on a
blackboard for quantification of the atherosclerotic lesion
area, which is commonly represented as a percent of total
intimal surface. Due to the fact that it does not consider the
lesion thickness, which can be determined either by histo-
logical sectioning or by measuring the amount of unester-
ified and esterified cholesterol, the procedure is limited in
the sense that it is a two-dimensional technique for the
measurement of atherosclerotic lesions (11-15).
Chemical analysis of atherosclerosis of the
aorta
Atherosclerotic lesion intensity can also be quantitatively
determined by measurement of free cholesterol and total
cholesterol in the whole aorta. In this case, the adventitia has
to be painstakingly and completely dissected and removed
from the aorta under a dissecting microscope, but this is a
time-consuming and cumbersome procedure. Lipids from
the aortic intima and media preparation are then extracted
with chloroform-methanol (2:1) using 5 α-cholestane as an
internal standard and total, free and esterified cholesterol
concentrations are quantified either by gas-liquid chroma-
tography (16) or by commercially available enzymatic kits. In
the latter, the first step is carried out only with cholesterol
oxidase for the measurement of unesterified cholesterol,
and then cholesteryl ester hydrolase is added for the meas-
urement of total cholesterol, with the esterified component
being the difference between the total cholesterol and the
unesterified fraction (17-20).
Serial histological analysis of atherosclerosis
of the aorta
Serial histological sectioning is the usual procedure for
tissue investigations. In most situations, tissues have to be
thinly sectioned using a microtome. Ideal microscopic
preparations should contain not only the structural compo-
nents, but also the molecular and chemical components as
well preserved as possible, mirroring the tissue of a living
animal. In other words, to avoid autolysis or post-mortem
degradation, biological materials are subjected to fixation
procedures for the preservation, stabilization and mainte-
nance of the structure of the organs, tissues and their cells
(13). Thus, the choice between a chemical and a physical
fixation depends on which lesion feature the investigator
wishes to demonstrate. Chemical fixation with phosphate-
buffered 4% formaldehyde or 4% paraformaldehyde and
gelatin inclusion to obtain proper arterial stiffness has
been extensively used (21,22). However, physical fixation
by sample freezing using optimal cutting temperature em-
bedding medium (Tissue-Tek, Sakura Finetek, USA) and
liquid nitrogen is indicated to preserve the structural com-
ponents of the artery and the integrity of the chemical
components (23-25). The physical fixation limits the loss of
chemical components. Sample sectioning is then carried
out at low temperature (-18 to -30°C) with a cryostat.
After the chemical or physical fixation, staining of histo-
logical sections for lipid analysis is generally carried out
with fat-soluble dyes, such as oil red-O, Sudan IV and
Sudan black. Atherosclerosis measurement can then be
expressed as the lesion cross-sectional area.
Method choice
Since there are several methods for the measurement
of atherosclerosis, each of them with its peculiarities, we
illustrate here their applicability with specific examples.
Depending on the mouse model used, a high-fat diet
can elicit blood cholesterol concentrations as high as 1000
mg/dL, which far exceeds the values observed in the most
severe forms of familial hypercholesterolemia in humans.
The animal’s age during the study period is another impor-
tant factor to be considered since in old animals fed regular
chow, such as apoE KO, atherosclerotic lesions grow in
size and develop gradually in complexity (22). Atheroscle-
rotic lesions can be observed grossly even during dissec-
tion of the mouse aorta (Figure 1). Very often these experi-
mental situations result in extensive lesion development
along the aorta and atherosclerotic lesions are then quite
often assessed by en face analysis of the whole aorta
(15,22). Nevertheless, it has been shown that the sensitiv-
473
Braz J Med Biol Res 42(6) 2009
Assessment of experimental atherosclerosis
www.bjournal.com.br
ity of this technique is low both for groups fed on a regular
mouse chow and for young animals, and may not accu-
rately measure the degree of the lesions (11,12). Further-
more, in this two-dimensional analysis, the thickness of the
lesion is not taken into account.
The degree of mouse atherosclerosis can also be
accurately obtained by the cholesterol quantification men-
tioned above (17,19,20), which is highly sensitive for the
detection of early and advanced atherosclerosis lesions,
but misses the identification of the lesion location and
complexity, so critical for humans (19) in whom lesions are
better measured by cross-sectional aortic histology (19,24).
Although extremely laborious, the latter is sensitive enough
to distinguish premature from advanced lesions. This situ-
ation can be illustrated by LDLR KO and apoE KO mice fed
a low-sodium chloride diet (25). After being fed a low-
sodium chloride diet for 9 weeks, LDLR KO mice devel-
oped premature arterial lipid storage identified by cross-
sectional aortic histology and that might be missed by the
en face examination of the aortic arch (Figure 2). On the
other hand, in humans location and complexity of the
lesions are critical parameters that determine the severity
of the complication, such as thrombosis, plaque rupture,
and the organ or tissue affected. Furthermore, LDL me-
Figure 1. Gross appearance of atherosclerotic lesions indicated
by the arrows in an 8-month-old male apolipoprotein E knockout
mouse fed a chow diet. Total serum cholesterol was about 450-
500 mg/dL.
Figure 2. Representative light micrographs of mice cross-sectional arterial aortic arch wall lipid deposit areas (intima and media)
stained with oil red-O and counterstained with hematoxylin. Panels A and B: Apolipoprotein E knockout (apoE KO) mice; panels C and
D: lipoprotein receptor knockout (LDLR KO) mice. The animals were fed a normal sodium chloride diet (panels A and C) and a low-
sodium chloride diet (panels B and D) for nine weeks (25). Remarkable aortic fat infiltration is observed in apoE KO mice (A and B)
compared to the aortic wall of LDLR KO mice (C and D). Nonetheless, the low-sodium chloride diet increased the arterial fat
accumulation in LDLR KO mice but caused no changes in apoE KO mice. These premature lesions, indicated by the arrows, could
only be identified by cross-sectional analysis and not by the en face aortic examination.
50 μm 50 μm
50 μm 50 μm
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tabolism, either in plasma or in cell culture, may be influ-
enced by differences in fatty acid composition of the cho-
lesteryl ester component of the LDL particles (17,21,26).
Consequently, although similar arterial cholesteryl ester
contents may be found in the experimental groups, the
complexity of the atherosclerotic lesion may differ signifi-
cantly. The opposite may also be true, since it has been
shown that simvastatin dramatically reduces the accumu-
lation of cholesterol in the whole aorta in apoE KO mice
during a 6-week treatment period; nevertheless, the histo-
logical analysis of the aortic root lesions from simvastatin-
treated and control animals reveals similar lesion morphol-
ogy. In this case, the effect of simvastatin treatment on the
aortic root lesion complexity seems to have little signifi-
cance when compared to the effect on the cholesteryl ester
content in the remainder of the aortic segments (23). In
other words, although the cholesterol content of the aortic
arch strongly correlates with the degree of atherosclerosis
shown by the morphometric technique, the biological and
clinical significance obtained by these procedures may
markedly differ (19).
Acyl CoA:cholesterol acyltransferase (ACAT) catalyzes
the intracellular cholesterol esterification (27,28). Histo-
logical analyses of tissues and atherosclerotic lesions
have shown that double KO mice for ACAT1 and for apoE,
or for LDLR, develop atherosclerotic lesions. However, in
addition to the loss of cholesteryl ester, ACAT1 deficiency
causes qualitative differences in atherosclerotic lesions
and markedly decreases the macrophage content in ad-
vanced lesions (29). Thus, chemical measurements of the
esterified cholesterol content would be of little help to
define the degree of aortic atherosclerosis and therefore
histological analysis would be more appropriate.
Finally, histological analyses deserve criticism because
the chemical fixation and inclusion may extract the tissue
fat, and also shrink and distort the tissue structures. Thus,
this method may be less sensitive for the detection of slight
differences among the experimental groups, unless a more
suitable procedure based on physical fixation with histo-
logical sample freezing using optimal cutting temperature
and liquid nitrogen is employed.
Although experimental atherosclerosis can be assessed
using advanced imaging techniques such as angiography,
Doppler ultrasound, B-mode ultrasound and magnetic reso-
nance (30-32), the main methods employed in the quanti-
fication of mouse atherosclerosis are those mentioned in
this brief review.
Conclusion
We conclude that, when measuring experimental ath-
erosclerosis in mice, investigators should be aware of
several pitfalls regarding degrees of arterial lesions con-
sidered suitable for human pathology. Depending upon
the experimental protocols, animal atherosclerosis may
vary in intensity, complexity and location. These aspects
demand properly sensitive methods of experimental ath-
erosclerosis development and the interpretation and ex-
trapolation of the findings to human pathology demand
caution.
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